Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Business Insights
PictorLabs raises $30M in series B financing round
By
LabPulse.com staff writers
Digital pathology software firm PictorLabs has successfully completed its $30 million series B funding round.
September 19, 2024
Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims
By
LabPulse.com staff writers
Among the tests in focus are certain RNA- and DNA-based tests.
September 19, 2024
Eurofins Genomics US opens new manufacturing facility
By
LabPulse.com staff writers
Eurofins Genomics US announced the opening of its new U.S. oligonucleotide manufacturing facility.
September 20, 2024
Scancell, PharmaJet sign agreement for melanoma vaccine delivery system
By
LabPulse.com staff writers
Clinical-stage biopharmaceutical company Scancell has signed a strategic partnership agreement with PharmaJet for the supply of PharmaJet's needle-free Stratis delivery system for the delivery of Scancell's advanced melanoma vaccine.
September 18, 2024
Independent directors of 23andMe resign
By
LabPulse.com staff writers
The seven independent directors of genetic testing company 23andMe resigned on September 17, saying they had not yet received a satisfactory take-private proposal from CEO Anne Wojcicki five months after she made the offer.
September 18, 2024
CDC adds commercial lab contracts for infectious disease, bird flu testing
By
Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Multiregional clinical trial data on FDA watch for U.S. applicability
By
LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
FDA clears marketing T2 Biosystems Candida test for pediatrics
By
LabPulse.com staff writers
T2Candida Panel may get a boost.
September 16, 2024
PathPresenter raises $7.7M in series A funding for digital pathology platform
By
LabPulse.com staff writers
Digital pathology firm PathPresenter has closed a series A funding round of $7.5 million, which the firm says it will use to accelerate the adoption of its enterprise pathology platform.
September 13, 2024
LuminUltra acquires Genomadix Legionella test assets
By
LabPulse.com staff writers
LuminUltra has acquired the Legionella testing business assets of Genomadix, as well as the rights to develop and commercialize further assays and test methods.
September 10, 2024
BillionToOne to open new facility in Austin, Texas
By
LabPulse.com staff writers
Molecular diagnostics firm BillionToOne broke ground on a 220,000-sq-ft facility in Austin, TX, that is expected to bring 1,000 jobs to the city.
September 12, 2024
Oxford Nanopore files for subpoenas, claims BGI Group contractual breach
By
LabPulse.com staff writers
Oxford Nanopore Technologies announced that it intends to sue BGI Group and its subsidiaries for breach of contractual obligations as well as potential breach of patent licensing.
September 11, 2024
Page 1 of 189
Next Page